U24 AG059624, P30 AG021332, and P30 AG044271], the San Antonio VA Geriatric Research Education and Clinical Center, and the Colorado Clinical and Translational Sciences Institute [UM1 TR004399]
,
A long half-life of roughly 6 days makes a single weekly subcutaneous injection practical, while gradual titration keeps the protocol comfortable from the very first dose
Some common reasons include: Insurance formulary changes : Your insurance may no longer cover your current GLP-1 or may start preferring a different brand-name option
Because these chemicals may remain in the body for long periods, adipose tissue can act as a storage compartment
GLP-1 receptor agonists are typically prescribed for individuals with obesity (defined as a BMI of 30 or higher) or overweight individuals (BMI of 27 or higher) who also have weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea